Imagion Biosystems Limited (IBX.AX)

AUD 0.02

(5.56%)

Revenue Summary of Imagion Biosystems Limited

Imagion Biosystems Limited's latest annual revenue in 2023 was 1.36 Million AUD , up 128.74% from previous year.
Imagion Biosystems Limited's latest quarterly revenue in 2024 Q2 was 817.52 Thousand AUD , down 0.0% from previous quarter.
Imagion Biosystems Limited reported a annual revenue of 473.42 Thousand AUD in annual revenue 2022, up 103.31% from previous year.
Imagion Biosystems Limited reported a annual revenue of 232.86 Thousand AUD in annual revenue 2021, up 13.2% from previous year.
Imagion Biosystems Limited reported a quarterly revenue of 817.52 Thousand AUD for 2024 Q1, up 9.49% from previous quarter.
Imagion Biosystems Limited reported a quarterly revenue of 690.01 Thousand AUD for 2023 Q2, up 100.0% from previous quarter.

Annual Revenue Chart of Imagion Biosystems Limited (2023 - 2014)

Historical Annual Revenue of Imagion Biosystems Limited (2023 - 2014)

Year	Revenue	Revenue Growth
2023	1.36 Million AUD	128.74%
2022	473.42 Thousand AUD	103.31%
2021	232.86 Thousand AUD	13.2%
2020	205.71 Thousand AUD	-49.93%
2019	410.85 Thousand AUD	114.57%
2018	191.47 Thousand AUD	852.53%
2017	20.1 Thousand AUD	167416.67%
2016	12.00 AUD	-99.78%
2015	5492.60 AUD	-10.11%
2014	6110.25 AUD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	817.52 Thousand AUD	0.0%
2024 Q1	817.52 Thousand AUD	9.49%
2023 Q2	690.01 Thousand AUD	100.0%
2023 Q4	746.66 Thousand AUD	-65.11%
2023 FY	1.08 Million AUD	128.74%
2023 Q1	345 Thousand AUD	13.42%
2023 Q3	2.14 Million AUD	210.19%
2022 Q3	1.4 Million AUD	427.76%
2022 Q2	265.76 Thousand AUD	100.0%
2022 FY	473.42 Thousand AUD	103.31%
2022 Q1	132.88 Thousand AUD	77.74%
2022 Q4	304.19 Thousand AUD	-78.31%
2021 Q2	168.64 Thousand AUD	-87.87%
2021 FY	232.86 Thousand AUD	13.2%
2021 Q4	74.76 Thousand AUD	100.0%
2021 Q1	1.39 Million AUD	261.78%
2021 Q3	37.38 Thousand AUD	-77.83%
2020 Q1	1.15 Million AUD	775.74%
2020 FY	205.71 Thousand AUD	-49.93%
2020 Q4	384.32 Thousand AUD	100.0%
2020 Q3	192.16 Thousand AUD	64.11%
2020 Q2	117.09 Thousand AUD	-89.87%
2019 FY	410.85 Thousand AUD	114.57%
2019 Q4	132.04 Thousand AUD	100.0%
2019 Q3	66.02 Thousand AUD	-78.04%
2019 Q2	300.67 Thousand AUD	-74.5%
2019 Q1	1.17 Million AUD	1867.03%
2018 Q1	125.8 Thousand AUD	156.53%
2018 FY	191.47 Thousand AUD	852.53%
2018 Q4	59.93 Thousand AUD	0.0%
2018 Q3	59.93 Thousand AUD	-52.36%
2018 Q2	125.8 Thousand AUD	-0.0%
2017 Q3	49.04 Thousand AUD	-59.3%
2017 FY	20.1 Thousand AUD	167416.67%
2017 Q2	120.48 Thousand AUD	0.0%
2017 Q1	120.48 Thousand AUD	2297.49%
2017 Q4	49.04 Thousand AUD	0.0%
2016 Q4	5025.50 AUD	0.0%
2016 Q1	- AUD	0.0%
2016 FY	12.00 AUD	-99.78%
2016 Q2	- AUD	0.0%
2015 Q4	- AUD	0.0%
2015 FY	5492.60 AUD	-10.11%
2014 FY	6110.25 AUD	0.0%

Peer Revenue Comparison of Imagion Biosystems Limited

Name	Revenue	Revenue Difference
Australian Clinical Labs Limited	689.72 Million AUD	99.802%
BCAL Diagnostics Limited	3.09 Million AUD	55.861%
Genetic Signatures Limited	9.76 Million AUD	85.998%
Genetic Technologies Limited	7.66 Million AUD	82.159%
Healius Limited	1.74 Billion AUD	99.922%
Integral Diagnostics Limited	469.69 Million AUD	99.709%
INOVIQ Ltd	535.11 Thousand AUD	-155.547%
Microba Life Sciences Limited	12.09 Million AUD	88.689%
Monash IVF Group Limited	254.96 Million AUD	99.464%
Rhythm Biosciences Limited	1.69 Million AUD	19.091%
Sonic Healthcare Limited	8.93 Billion AUD	99.985%